Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$10.37 - $12.73 $729,736 - $895,810
-70,370 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$10.21 - $15.27 $16,336 - $24,432
-1,600 Reduced 2.22%
70,370 $790,000
Q3 2021

Nov 15, 2021

BUY
$14.07 - $17.3 $239,555 - $294,549
17,026 Added 30.99%
71,970 $1.05 Million
Q2 2021

Aug 13, 2021

BUY
$16.62 - $18.94 $12,581 - $14,337
757 Added 1.4%
54,944 $953,000
Q1 2021

May 14, 2021

BUY
$15.15 - $19.78 $5,544 - $7,239
366 Added 0.68%
54,187 $936,000
Q4 2020

Feb 12, 2021

BUY
$16.86 - $19.67 $13,960 - $16,286
828 Added 1.56%
53,821 $993,000
Q3 2020

Nov 16, 2020

SELL
$15.4 - $20.16 $361,669 - $473,457
-23,485 Reduced 30.71%
52,993 $919,000
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $16,142 - $18,983
-885 Reduced 1.14%
76,478 $1.4 Million
Q1 2020

May 14, 2020

BUY
$16.28 - $25.63 $54,831 - $86,321
3,368 Added 4.55%
77,363 $1.57 Million
Q4 2019

Feb 13, 2020

BUY
$19.57 - $23.52 $11,742 - $14,112
600 Added 0.82%
73,995 $1.74 Million
Q3 2019

Nov 13, 2019

BUY
$19.85 - $22.76 $646,296 - $741,042
32,559 Added 79.73%
73,395 $1.49 Million
Q2 2019

Aug 14, 2019

BUY
$17.59 - $21.1 $11,785 - $14,137
670 Added 1.67%
40,836 $885,000
Q1 2019

May 14, 2019

BUY
$18.01 - $20.11 $20,963 - $23,408
1,164 Added 2.98%
40,166 $825,000
Q4 2018

Feb 13, 2019

SELL
$17.44 - $21.53 $17,317 - $21,379
-993 Reduced 2.48%
39,002 $706,000
Q3 2018

Nov 13, 2018

BUY
$19.97 - $21.96 $16,335 - $17,963
818 Added 2.09%
39,995 $881,000
Q2 2018

Aug 14, 2018

BUY
$20.16 - $24.68 $460,615 - $563,888
22,848 Added 139.92%
39,177 $863,000
Q1 2018

May 11, 2018

BUY
$20.31 - $24.95 $30,688 - $37,699
1,511 Added 10.2%
16,329 $361,000
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $46,639 - $53,083
2,222 Added 17.64%
14,818 $351,000
Q3 2017

Nov 13, 2017

BUY
$20.07 - $21.89 $252,801 - $275,726
12,596
12,596 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.06B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.